FDA Inspection 657000 — Oklahoma Blood Institute Southern
The FDA completed an inspection of Oklahoma Blood Institute Southern on April 13, 2010 in Ardmore, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 13, 2010
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ardmore, OK (United States)